Home › Funds › Royce & Associates › FATE
Royce & Associates position in FATE
FATE THERAPEUTICS INC · Health Care
Latest position (Q1 2024)43.40K sh
Reported value held$318.55K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 30.34K | $64.32K | New |
| Q4 2023 | 107.32K | $401.37K | Add |
| Q1 2024 | 43.40K | $318.55K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- BlackRock Inc 7.30M sh · $19.71M · Q2 2026
- AQR Capital Management 3.84M sh · $10.36M · Q2 2026
- Two Sigma Investments 3.59M sh · $9.69M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- Goldman Sachs Group 2.05M sh · $5.53M · Q2 2026
- Geode Capital Management 1.32M sh · $3.57M · Q2 2026
- Citadel Advisors 1.09M sh · $2.95M · Q2 2026
- Morgan Stanley 694.58K sh · $1.88M · Q2 2026
- Charles Schwab Investment Management 610.95K sh · $1.65M · Q2 2026
- UBS Group AG 590.18K sh · $1.59M · Q2 2026